Causes of drug resistance and glioblastoma relapses

Glioblastoma multiform^ is one of the most aggressive malignancies, wich standard of treatment not changed over the past decade, and the average life expectancy from diagnosis to death does not exceed two years in the most optimistic trials. The review examines the features of the glioblastoma micro...

Full description

Bibliographic Details
Main Authors: A. A. Mitrofanov, D. R. Naskhletashvili, V. A. Aleshin, D. M. Belov, A. Kh. Bekyashev, V. B. Karakhan, N. V. Sevyan, E. V. Prozorenko, K. E. Roshchina
Format: Article
Language:Russian
Published: ABV-press 2021-04-01
Series:Opuholi Golovy i Šei
Subjects:
Online Access:https://ogsh.abvpress.ru/jour/article/view/615